These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. P&T Committee review of fluconazole: an effective alternative to antifungal therapy. Neu HC, Bennett JE, Bodey GP, Rubin RH, Schentag JJ, Sugar AM. Hosp Formul; 1990 Mar; 25 Suppl B():9-14. PubMed ID: 10103976 [Abstract] [Full Text] [Related]
3. Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Grant SM, Clissold SP. Drugs; 1990 Jun; 39(6):877-916. PubMed ID: 2196167 [Abstract] [Full Text] [Related]
4. The triazole antifungal agents: a review of itraconazole and fluconazole. Bailey EM, Krakovsky DJ, Rybak MJ. Pharmacotherapy; 1990 Jun; 10(2):146-53. PubMed ID: 2161523 [Abstract] [Full Text] [Related]
5. Current drug therapy of systemic mycoses: a review. Yonga G. East Afr Med J; 1995 Jun; 72(6):394-8. PubMed ID: 7498014 [Abstract] [Full Text] [Related]
6. Pharmacokinetics of oral antifungals and their clinical implications. Heykants J, Van Peer A, Lavrijsen K, Meuldermans W, Woestenborghs R, Cauwenbergh G. Br J Clin Pract Suppl; 1990 Sep; 71():50-6. PubMed ID: 1965419 [Abstract] [Full Text] [Related]
7. Fluconazole: a new triazole antifungal agent. Pasko MT, Piscitelli SC, Van Slooten AD. DICP; 1990 Sep; 24(9):860-7. PubMed ID: 2260347 [Abstract] [Full Text] [Related]
14. Fluconazole vs amphotericin B: "in vitro" comparative evaluation of the minimal inhibitory concentration (MIC) against yeasts isolated from AIDS patients. Lombardi G, Gramegna G, Cavanna C, Michelone G. Microbiologica; 1990 Jul 10; 13(3):201-6. PubMed ID: 2273982 [Abstract] [Full Text] [Related]
15. [Therapy of candidiasis and cryptococcosis in AIDS]. Just-Nübling G. Mycoses; 1994 Jul 10; 37 Suppl 2():56-63. PubMed ID: 7609745 [Abstract] [Full Text] [Related]
16. Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions. Yu DT, Peterson JF, Seger DL, Gerth WC, Bates DW. Pharmacoepidemiol Drug Saf; 2005 Nov 10; 14(11):755-67. PubMed ID: 15654717 [Abstract] [Full Text] [Related]
17. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies. Johnson E, Espinel-Ingroff A, Szekely A, Hockey H, Troke P. Int J Antimicrob Agents; 2008 Dec 10; 32(6):511-4. PubMed ID: 18790613 [Abstract] [Full Text] [Related]